Giovanna Devercelli

987 total citations
30 papers, 679 citations indexed

About

Giovanna Devercelli is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giovanna Devercelli has authored 30 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giovanna Devercelli's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Colorectal Cancer Treatments and Studies (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). Giovanna Devercelli is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Colorectal Cancer Treatments and Studies (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). Giovanna Devercelli collaborates with scholars based in United States, United Kingdom and Germany. Giovanna Devercelli's co-authors include Monika Stender, Lynda Bryant‐Comstock, Gagan Jain, Marc Peeters, Aleena Banerji, Eric Van Cutsem, Michael Wolf, Salvatore Siena, T. Michelle Brown and Shannon Hunter and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Giovanna Devercelli

26 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giovanna Devercelli United States	12	213	195	152	118	104	30	679
Delphine Bertrand Belgium	13	39 0.2×	140 0.7×	175 1.2×	27 0.2×	28 0.3×	41	506
Solange Mongoue‐Tchokote United States	12	98 0.5×	127 0.7×	170 1.1×	33 0.3×	9 0.1×	23	451
Jessica Weiss Canada	14	37 0.2×	191 1.0×	172 1.1×	31 0.3×	87 0.8×	55	753
David E. Dawe Canada	15	55 0.3×	212 1.1×	280 1.8×	63 0.5×	20 0.2×	56	749
AH Partridge United States	6	69 0.3×	307 1.6×	103 0.7×	40 0.3×	85 0.8×	30	754
Ellen Friedman United States	12	76 0.4×	150 0.8×	58 0.4×	73 0.6×	13 0.1×	25	660
Karen Sweiss United States	13	188 0.9×	145 0.7×	46 0.3×	55 0.5×	11 0.1×	83	578
G. R. Langley Canada	16	209 1.0×	165 0.8×	70 0.5×	127 1.1×	15 0.1×	38	879
Namita Tundia United States	14	48 0.2×	43 0.2×	42 0.3×	37 0.3×	30 0.3×	40	621
Robin Stuart‐Harris Australia	17	45 0.2×	415 2.1×	162 1.1×	70 0.6×	29 0.3×	32	725

Countries citing papers authored by Giovanna Devercelli

Since Specialization

Citations

This map shows the geographic impact of Giovanna Devercelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanna Devercelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanna Devercelli more than expected).

Fields of papers citing papers by Giovanna Devercelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanna Devercelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanna Devercelli. The network helps show where Giovanna Devercelli may publish in the future.

Co-authorship network of co-authors of Giovanna Devercelli

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanna Devercelli. A scholar is included among the top collaborators of Giovanna Devercelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanna Devercelli. Giovanna Devercelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watt, Maureen, Saeid Shahraz, Sara Costa-Cabral, et al.. (2023). Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema. Journal of Patient-Reported Outcomes. 7(1). 33–33. 7 indexed citations

Lumry, William R., Marcus Maurer, Karsten Weller, et al.. (2023). Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema. Annals of Allergy Asthma & Immunology. 131(1). 101–108.e3. 11 indexed citations

Watt, Maureen, Marcus Maurer, William R. Lumry, et al.. (2023). Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study. Journal of Allergy and Clinical Immunology. 151(2). AB139–AB139.

Hughes, Derralynn, et al.. (2023). Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation. Journal of health economics and outcomes research. 80–88.

Welsing, Paco M J, et al.. (2023). Clinical Validation of a Primary Antibody Deficiency Screening Algorithm for Primary Care. Journal of Clinical Immunology. 43(8). 2022–2032. 3 indexed citations

Mayampurath, Anoop, Colin Anderson‐Smits, Shun‐Chiao Chang, et al.. (2022). Early Diagnosis of Primary Immunodeficiency Disease Using Clinical Data and Machine Learning. The Journal of Allergy and Clinical Immunology In Practice. 10(11). 3002–3007.e5. 21 indexed citations

Mendívil, Joan, et al.. (2021). Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses. Drugs in R&D. 21(1). 113–121. 5 indexed citations

Mendívil, Joan, Ellen M. Janssen, Henrik Balle Boysen, et al.. (2021). Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey. Orphanet Journal of Rare Diseases. 16(1). 94–94. 44 indexed citations

Lumry, William R., Karsten Weller, Markus Magerl, et al.. (2020). Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study. Allergy. 76(4). 1188–1198. 38 indexed citations

10.

Kovács, Gábor G., Giovanna Devercelli, Tamás Zelei, et al.. (2020). Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis. PLoS ONE. 15(4). e0231646–e0231646. 8 indexed citations

11.

Banerji, Aleena, Kimberly H. Davis, T. Michelle Brown, et al.. (2020). Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States. Annals of Allergy Asthma & Immunology. 124(6). 600–607. 97 indexed citations

12.

Augustine, Titus, John S. Gill, Klemens Budde, et al.. (2019). INTERNATIONAL, MATCHED-COHORT CHECKERBOARD STUDY OF QUALITY OF LIFE AND DISEASE BURDEN IN KIDNEY TRANSPLANT (TX) PATIENTS WITH ANTIBODY-MEDIATED REJECTION (AMR). Transplant International. 32. 310–310. 1 indexed citations

13.

Yu, Yanni, et al.. (2016). Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis. Journal of Managed Care & Specialty Pharmacy. 22(4). 414–423. 33 indexed citations

14.

Moretz, Chad, Yunping Zhou, Amol D. Dhamane, et al.. (2015). Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy. 21(12). 1149–1159. 8 indexed citations

15.

Chirila, Costel, Dawn Odom, Giovanna Devercelli, et al.. (2011). Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. International Journal of Colorectal Disease. 27(5). 623–634. 25 indexed citations

16.

Colwell, Hilary H., Susan D. Mathias, Michelle Turner, et al.. (2010). Psychometric Evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): Reliability, Validity, Responsiveness, and Clinical Meaningfulness. The Oncologist. 15(3). 308–316. 21 indexed citations

17.

Peeters, Marc, Salvatore Siena, Eric Van Cutsem, et al.. (2009). Association of progression‐free survival, overall survival, and patient‐reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy. Cancer. 115(7). 1544–1554. 106 indexed citations

18.

Graham, Colin A., Rohit Borker, Mark Oppe, et al.. (2008). COST-EFFECTIVENESS OF PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) COMPARED WITH BSC ALONE IN CHEMOREFRACTORY METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) WITH WILD-TYPE (WT) KRAS TUMOR STATUS IN THE NETHERLANDS. Ghent University Academic Bibliography (Ghent University). 3 indexed citations

19.

Siena, Salvatore, Marc Peeters, Eric Van Cutsem, et al.. (2007). Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. British Journal of Cancer. 97(11). 1469–1474. 65 indexed citations

20.

Bryant‐Comstock, Lynda, Monika Stender, & Giovanna Devercelli. (2002). Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disorders. 4(6). 398–405. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact